A class action lawsuit was filed against Inspire Medical Systems ($INSP) on November 6, 2025. Plaintiffs in the federal ...

Inspire Medical Systems (INSP) has quietly staged a sharp rebound, with shares up about 10% over the past week and nearly 65% in the past month, drawing fresh attention to its sleep apnea franchise.

Around 22 million Americans have sleep apnea. Traditional continuous positive airway pressure, or CPAP, machines are the standard treatment. However, they can be loud, uncomfortable and have a pesky ...

Inspire Medical Systems has reported a significant 84% rise in Q1 2023 revenue, reaching $127.9 million, driven by its innovative treatments for Obstructive Sleep Apnea. The company has received FDA ...

The average one-year price target for Inspire Medical Systems (NYSE:INSP) has been revised to 338.64 / share. This is an increase of 5.56% from the prior estimate of 320.79 dated June 1, 2023. The ...

What Happened? Shares of medical technology company Inspire Medical Systems (NYSE:INSP) jumped 3% in the afternoon session after RBC Capital significantly raised its price target on the stock. The ...

Similarly, Truist Securities upgraded Inspire Medical Systems to Buy, raising its price target to $165 due to a favorable reimbursement upcode. Oppenheimer also upgraded the stock to Outperform, ...

The FDA has labeled a recall of Inspire Medical Systems, Inc.’s (NYSE:INSP) nerve-stimulating implant for obstructive sleep apnea as Class I, the most serious kind. Inspire initiated a recall of its ...

Inspire is scheduled to present at 12:45 p.m. Eastern Time. The presentation will be accessible via a live webcast here. A webcast replay of the presentation will be available for two weeks following ...